Guangdong VTR Bio-Tech Co Ltd (300381) — Net Asset Quality Index
Guangdong VTR Bio-Tech Co Ltd (300381) has a Net Asset Quality Index of 90.7% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.88 Billion minus total liabilities of CN¥266.84 Million yields net assets of CN¥2.61 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 300381 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Guangdong VTR Bio-Tech Co Ltd Net Asset Quality Index Over Time (2007–2025)
This chart shows how Guangdong VTR Bio-Tech Co Ltd's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of March 2026, the index stands at 90.7%, representing net assets of CN¥2.61 Billion against total assets of CN¥2.88 Billion CNY. Explore 300381 cash flow metrics to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Guangdong VTR Bio-Tech Co Ltd (2007–2025)
The table below presents the year-by-year Net Asset Quality Index for Guangdong VTR Bio-Tech Co Ltd from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 300381 company net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 88.7% | CN¥2.59 Billion | CN¥2.92 Billion | CN¥331.81 Million | ▼ -1.4 pp |
| 2024 | 90.0% | CN¥2.65 Billion | CN¥2.95 Billion | CN¥294.39 Million | ▲ +1.6 pp |
| 2023 | 88.4% | CN¥2.74 Billion | CN¥3.09 Billion | CN¥359.79 Million | ▼ -0.4 pp |
| 2022 | 88.8% | CN¥2.82 Billion | CN¥3.17 Billion | CN¥356.26 Million | ▲ +20.7 pp |
| 2021 | 68.0% | CN¥3.05 Billion | CN¥4.48 Billion | CN¥1.43 Billion | ▼ -1.8 pp |
| 2020 | 69.8% | CN¥3.26 Billion | CN¥4.67 Billion | CN¥1.41 Billion | ▲ +9.4 pp |
| 2019 | 60.4% | CN¥2.73 Billion | CN¥4.52 Billion | CN¥1.79 Billion | ▲ +10.3 pp |
| 2018 | 50.1% | CN¥2.41 Billion | CN¥4.80 Billion | CN¥2.39 Billion | ▼ -4.2 pp |
| 2017 | 54.4% | CN¥2.09 Billion | CN¥3.85 Billion | CN¥1.76 Billion | ▼ -9.7 pp |
| 2016 | 64.0% | CN¥2.05 Billion | CN¥3.21 Billion | CN¥1.16 Billion | ▲ +6.3 pp |
| 2015 | 57.7% | CN¥1.42 Billion | CN¥2.45 Billion | CN¥1.04 Billion | ▼ -13.4 pp |
| 2014 | 71.1% | CN¥685.38 Million | CN¥963.36 Million | CN¥277.98 Million | ▼ -10.1 pp |
| 2013 | 81.3% | CN¥305.76 Million | CN¥376.14 Million | CN¥70.39 Million | ▼ -0.6 pp |
| 2012 | 81.9% | CN¥242.72 Million | CN¥296.37 Million | CN¥53.65 Million | ▲ +9.4 pp |
| 2011 | 72.5% | CN¥188.00 Million | CN¥259.27 Million | CN¥71.27 Million | ▲ +9.2 pp |
| 2010 | 63.3% | CN¥144.81 Million | CN¥228.77 Million | CN¥83.96 Million | ▼ -0.2 pp |
| 2009 | 63.5% | CN¥123.79 Million | CN¥194.90 Million | CN¥71.11 Million | ▲ +6.1 pp |
| 2008 | 57.4% | CN¥98.12 Million | CN¥170.86 Million | CN¥72.74 Million | ▼ -5.3 pp |
| 2007 | 62.7% | CN¥77.75 Million | CN¥123.95 Million | CN¥46.20 Million | — |